Literature DB >> 22968666

Attentional bias for prescription opioid cues among opioid dependent chronic pain patients.

Eric L Garland1, Brett E Froeliger, Steven D Passik, Matthew O Howard.   

Abstract

Recurrent use of prescription opioid analgesics by chronic pain patients may result in opioid dependence, which involves implicit neurocognitive operations that organize and impel craving states and compulsive drug taking behavior. Prior studies have identified an attentional bias (AB) towards heroin among heroin dependent individuals. The aim of this study was to determine whether opioid-dependent chronic pain patients exhibit an AB towards prescription opioid-related cues. Opioid-dependent chronic pain patients (n = 32) and a comparison group of non-dependent opioid users with chronic pain (n = 33) completed a dot probe task designed to measure opioid AB. Participants also rated their opioid craving and self-reported arousal associated with opioid-related and neutral images, pain severity, and relief from pain treatments. Repeated-measures ANOVA revealed a significant group (opioid-dependent vs. non-dependent opioid user) × presentation duration (200. vs. 2,000 ms.) interaction, such that opioid-dependent individuals evidenced a significant AB towards opioid cues presented for 200 ms but not for cues presented for 2,000 ms, whereas non-dependent opioid users did not exhibit a significant mean AB at either stimulus duration. Among opioid-dependent individuals, 200 ms opioid AB was significantly associated with opioid craving, while among non-dependent opioid users, 200 ms opioid AB was significantly associated with relief from pain treatments. Furthermore, dependent and non-dependent opioid users experienced opioid cues as significantly more arousing than neutral cues. Opioid dependence among chronic pain patients appears to involve an automatic AB towards opioid-related cues. When coupled with chronic pain, attentional fixation on opioid cues may promote compulsive drug use and addictive behavior.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968666      PMCID: PMC3548053          DOI: 10.1007/s10865-012-9455-8

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  59 in total

Review 1.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

Review 2.  Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches.

Authors:  Ingmar H A Franken
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-06       Impact factor: 5.067

Review 3.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

4.  Conditioning factors in drug abuse: can they explain compulsion?

Authors:  C P O'Brien; A R Childress; R Ehrman; S J Robbins
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

5.  Smoking abstinence and depressive symptoms modulate the executive control system during emotional information processing.

Authors:  Brett Froeliger; Leslie A Modlin; Rachel V Kozink; Lihong Wang; F Joseph McClernon
Journal:  Addict Biol       Date:  2011-11-15       Impact factor: 4.280

6.  Heroin-related attentional bias and monthly frequency of heroin use are positively associated in attenders of a harm reduction service.

Authors:  Louise Bearre; Patrick Sturt; Gillian Bruce; Barry T Jones
Journal:  Addict Behav       Date:  2006-07-13       Impact factor: 3.913

7.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

8.  Development and validation of the Current Opioid Misuse Measure.

Authors:  Stephen F Butler; Simon H Budman; Kathrine C Fernandez; Brian Houle; Christine Benoit; Nathaniel Katz; Robert N Jamison
Journal:  Pain       Date:  2007-05-09       Impact factor: 6.961

9.  Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Anna-Rose Childress; Millard Jayne; Yeming Ma; Christopher Wong
Journal:  Neuroimage       Date:  2007-10-11       Impact factor: 6.556

10.  De facto long-term opioid therapy for noncancer pain.

Authors:  Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Clin J Pain       Date:  2008 Jul-Aug       Impact factor: 3.442

View more
  23 in total

Review 1.  Pain and suicidality: insights from reward and addiction neuroscience.

Authors:  Igor Elman; David Borsook; Nora D Volkow
Journal:  Prog Neurobiol       Date:  2013-07-01       Impact factor: 11.685

2.  Partial Sleep Deprivation Attenuates the Positive Affective System: Effects Across Multiple Measurement Modalities.

Authors:  Patrick H Finan; Phillip J Quartana; Bethany Remeniuk; Eric L Garland; Jamie L Rhudy; Matthew Hand; Michael R Irwin; Michael T Smith
Journal:  Sleep       Date:  2017-01-01       Impact factor: 5.849

3.  Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.

Authors:  Harshini Neelakantan; Erica D Holliday; Robert G Fox; Sonja J Stutz; Sandra D Comer; Margaret Haney; Noelle C Anastasio; F Gerard Moeller; Kathryn A Cunningham
Journal:  ACS Chem Neurosci       Date:  2017-02-13       Impact factor: 4.418

4.  Behavioral preference for viewing drug v. pleasant images predicts current and future opioid misuse among chronic pain patients.

Authors:  Scott J Moeller; Adam W Hanley; Eric L Garland
Journal:  Psychol Med       Date:  2019-04-15       Impact factor: 7.723

5.  Low dispositional mindfulness predicts self-medication of negative emotion with prescription opioids.

Authors:  Eric L Garland; Adam W Hanley; Elizabeth A Thomas; Paul Knoll; Jeffrey Ferraro
Journal:  J Addict Med       Date:  2015 Jan-Feb       Impact factor: 3.702

Review 6.  A Patient-Tailored Evidence-Based Approach for Developing Early Neuropsychological Training Programs in Addiction Settings.

Authors:  Benjamin Rolland; Fabien D'Hondt; Solène Montègue; Mélanie Brion; Eric Peyron; Julia D'Aviau de Ternay; Philippe de Timary; Mikaïl Nourredine; Pierre Maurage
Journal:  Neuropsychol Rev       Date:  2019-01-03       Impact factor: 7.444

Review 7.  The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.

Authors:  Eric L Garland; Brett Froeliger; Fadel Zeidan; Kaitlyn Partin; Matthew O Howard
Journal:  Neurosci Biobehav Rev       Date:  2013-08-26       Impact factor: 8.989

8.  Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.

Authors:  Eric L Garland; Eron G Manusov; Brett Froeliger; Amber Kelly; Jaclyn M Williams; Matthew O Howard
Journal:  J Consult Clin Psychol       Date:  2014-02-03

9.  Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity.

Authors:  Eric L Garland; Brett Froeliger; Matthew O Howard
Journal:  Psychopharmacology (Berl)       Date:  2014-03-05       Impact factor: 4.530

10.  Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients.

Authors:  Eric L Garland; Matthew O Howard
Journal:  Drug Alcohol Depend       Date:  2014-10-02       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.